Biogenic pharma Ostarine Biogenic pharma

£67.00

Ostarine MK-2866 is a selective androgen receptor modulator developed by Biogenic Pharma for in-vitro laboratory research investigating muscle and bone tissue mechanisms.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Biogenic pharma Ostarine Biogenic pharma
Biogenic pharma Ostarine Biogenic pharma
£67.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Ostarine (MK-2866) Research Overview

Ostarine MK-2866 is a selective androgen receptor modulator (SARM) from the aryl-propionamide class, extensively studied for its tissue-selective androgenic properties. This Biogenic Pharma formulation provides researchers with a reliable compound to investigate androgen receptor modulation pathways in controlled laboratory environments. Scientists examining muscle and bone biology utilise Ostarine to analyse selective receptor binding mechanisms that demonstrate reduced androgenic activity in prostate tissue compared to traditional anabolic compounds.

Preclinical research has established Ostarine as the most clinically investigated SARM, with data from over 25 studies involving more than 1,700 subjects according to manufacturer reports. Researchers at Stroid UK Shop can access this compound for studies examining cancer-related cachexia, stress urinary incontinence, and sarcopenia mechanisms. The oral bioavailability confirmed in clinical trials makes it particularly valuable for pharmacokinetic research protocols.

Laboratory Applications

Research applications focus on studying androgen receptor selectivity in muscle and bone tissue models. Scientists investigate Ostarine’s binding affinity characteristics to understand tissue-specific receptor modulation mechanisms. Studies examine its effects on anabolic pathways while analysing reduced androgenic activity in prostate models compared to testosterone. Researchers utilising compounds from the broader SARMs collection often incorporate Ostarine as a reference standard for selective androgen receptor modulation studies.

Comparative studies with other research compounds from the peptides range help scientists understand different molecular pathways affecting muscle protein synthesis. Laboratory protocols examine Ostarine’s molecular mechanisms alongside complementary research compounds to investigate synergistic pathway interactions. Research teams studying the broader Ostarine category can compare formulations from different manufacturers to validate experimental consistency across research protocols.

Compound Specifications

Ostarine MK-2866 Research Data
Parameter Specification
CAS Registry 841205-47-8
Molecular Formula C₁₉H₁₄F₃N₃O₃
Molecular Weight 389.33 g/mol
Classification Non-steroidal SARM (aryl-propionamide)
Purity Verify with supplier
Storage Conditions Room temperature, dry environment

Research Compliance Statement

This Ostarine MK-2866 product is manufactured by Biogenic Pharma strictly for in-vitro laboratory research purposes only. This compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific research environments. Researchers must comply with institutional guidelines and local regulations governing research chemical handling and disposal protocols.

Related